CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells

• Archana Bommi-Reddy ,

  Contributed equally to this work with: Archana Bommi-Reddy, Sungmi Park-Chouinard, David N. Mayhew

  Roles Conceptualization, Formal analysis, Investigation, Project administration, Writing – original draft

  Affiliation Constellation Pharmaceuticals, a Morphosys Company, Cambridge, Massachusetts, United States of America

  ⨯
• Sungmi Park-Chouinard ,

  Contributed equally to this work with: Archana Bommi-Reddy, Sungmi Park-Chouinard, David N. Mayhew

  Roles Conceptualization, Formal analysis, Investigation, Visualization, Writing – original draft

  Affiliation Constellation Pharmaceuticals, a Morphosys Company, Cambridge, Massachusetts, United States of America

  ⨯
• David N. Mayhew ,

  Contributed equally to this work with: Archana Bommi-Reddy, Sungmi Park-Chouinard, David N. Mayhew

  Roles Data curation, Formal analysis, Software, Visualization, Writing – original draft

  Current address: Foghorn Therapeutics, Cambridge, Massachusetts, United States of America

  Affiliation Constellation Pharmaceuticals, a Morphosys Company, Cambridge, Massachusetts, United States of America

  ⨯
• Esteban Terzo,

  Roles Investigation

  Current address: Eloxx Pharmaceuticals, Watertown, Massachusetts, United States of America

  Affiliation Constellation Pharmaceuticals, a Morphosys Company, Cambridge, Massachusetts, United States of America

  ⨯
• Aparna Hingway,

  Roles Investigation

  Current address: Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  Affiliation Constellation Pharmaceuticals, a Morphosys Company, Cambridge, Massachusetts, United States of America

  ⨯
• Michael J. Steinbaugh,

  Roles Formal analysis, Software

  Current address: 28–7 Therapeutics, Cambridge, Massachusetts, United States of America

  Affiliation Constellation Pharmaceuticals, a Morphosys Company, Cambridge, Massachusetts, United States of America

  https://orcid.org/0000-0002-2403-2221

  ⨯
• Jonathan E. Wilson,

  Roles Conceptualization, Project administration

  Current address: Flare Therapeutics, Cambridge, Massachusetts, United States of America

  Affiliation Constellation Pharmaceuticals, a Morphosys Company, Cambridge, Massachusetts, United States of America

  ⨯
• Robert J. Sims III,

  Roles Conceptualization, Project administration

  Current address: Flare Therapeutics, Cambridge, Massachusetts, United States of America

  Affiliation Constellation Pharmaceuticals, a Morphosys Company, Cambridge, Massachusetts, United States of America

  ⨯
• Andrew R. Conery

  Roles Conceptualization, Formal analysis, Visualization, Writing – original draft

  * E-mail: arconery@gmail.com

  Current address: Triana Biomedicines, Waltham, Massachusetts, United States of America

  Affiliation Constellation Pharmaceuticals, a Morphosys Company, Cambridge, Massachusetts, United States of America

  https://orcid.org/0000-0003-3638-7633

  ⨯